vTv Therapeutics Inc. (VTVT:NASDAQ) rocketted at $3.1, representing a gain of 41.6%. On Thu 10 Dec 20, VTVT:NASDAQ hit a New 2-Week High of $2.19. The stock appeared on our News Catalysts scanner on Thu 10 Dec 20 at 08:04 PM in the 'BIOTECH' category. From Fri 27 Nov 20, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Wed 29 Jul 20 at $3.31 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About vTv Therapeutics Inc. (VTVT:NASDAQ)
vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes.
Top 10 Gainers:
- TPGY (TPGY:NYSE), 116.22%
- MACU (MACU:NASDAQ), 100%
- Solid Biosciences Inc. (SLDB:NASDAQ), 51.62%
- Equus Total Return, Inc. (EQS:NYSE), 46.9%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 42.65%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 41.55%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 41.29%
- NextDecade Corporation (NEXT:NASDAQ), 38%
- Recro Pharma, Inc. (REPH:NASDAQ), 36.81%
- FAT Brands Inc. (FAT:NASDAQ), 28.08%